Skip to content
healthcare.dev

OSELTAMIVIR PHOSPHATE

NDC 70710-1165, oseltamivir phosphate, for suspension, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1165
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209113
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1165 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSELTAMIVIR PHOSPHATE6 mg/mL

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
70710-1165-6707101165061 BOTTLE in 1 CARTON (70710-1165-6) / 60 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/432d9e7b-9cb2-4b7d-9fb2-015449096757
  • NADAC price for package 70710116506

    GET /v1/drugs/nadac/70710116506

Use it

Look up 70710-1165 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1165 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.